13F-HR filed by Palo Alto Investors LP
Palo Alto Investors LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 29 holding rows worth $1,056,915,561.
- Accession
- 0001306923-23-000014
- Filer
- CIK 1306923
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 29 entries on the cover page, a total value of $1,056,915,561 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,056,915,561 with VALUE read as dollars as filed, 13F file number 028-11013. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,831,035 | $162,009,977 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 5,889,491 | $148,709,648 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 575,907 | $130,080,114 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 10,524,022 | $127,972,108 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 381,282 | $97,993,287 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,657,458 | $79,972,349 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 5,228,609 | $59,972,145 | dollars as filed | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 1,374,822 | $55,240,348 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 2,405,793 | $50,136,726 | dollars as filed | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 1,005,776 | $20,698,870 | dollars as filed | |
| EHEALTH INC | 28238P109 | COM | 2,739,379 | $20,271,405 | dollars as filed | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 55,705 | $17,007,851 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 603,400 | $16,901,234 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 94,030 | $11,398,317 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 660,275 | $10,663,441 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 431,224 | $7,744,783 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 5,675,876 | $7,605,674 | dollars as filed | |
| NEVRO CORP | 64157F103 | COM | 386,832 | $7,434,911 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 472,600 | $6,862,152 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 6,530,288 | $5,438,424 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 111,717 | $3,291,183 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 732,400 | $2,197,200 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 64,700 | $2,044,520 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 166,069 | $1,484,657 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 278,985 | $1,205,215 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 160,800 | $1,074,144 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 656,200 | $780,878 | dollars as filed | |
| TACTILE SYSTEMS TECHNOLOGY I | 87357P100 | COMMON STOCK | 27,100 | $380,755 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 24,500 | $343,245 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001306923-23-000014 | this filing | 2023-11-14 | acceptance time not in the bulk data set |